-
1دورية أكاديمية
المؤلفون: Giuseppe Pelosi, MD, MIAC, Matteo Bulloni, PhD, Martina Vescio, PhD, Silvia Uccella, MD, Fabien Forest, MD, Giorgia Leone, MD, Massimo Barberis, MD, Daoud Rahal, MD, Paola Bossi, MD, Giovanna Finzi, MD, Deborah Marchiori, MD, Marco De Luca, MD, Fausto Sessa, MD, Sergio Harari, MD, Manuela Spinelli, MD, Patrizia Viola, MD, Paolo Macrì, MD, Stefania Maria, MD, Antonio Rizzo, MD, Antonio Picone, MD, Linda Pattini, PhD
المصدر: JTO Clinical and Research Reports, Vol 2, Iss 11, Pp 100222- (2021)
مصطلحات موضوعية: ΔNp63/p40, TTF-1, Lung, Non–small cell carcinoma, Prognosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Sergio Harari, Antonio Picone, Fabien Forest, Fausto Sessa, Giuseppe Pelosi, Paola Bossi, Silvia Uccella, A. G. Rizzo, Stefania Maria, Patrizia Viola, Deborah Marchiori, Marco De Luca, Giovanna Finzi, Paolo Macrì, Daoud Rahal, Linda Pattini, Massimo Barberis, Manuela Spinelli, Matteo Bulloni, Martina Vescio, Giorgia Leone
المصدر: JTO Clinical and Research Reports
JTO Clinical and Research Reports, Vol 2, Iss 11, Pp 100222-(2021)مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Angiogenesis, Squamous Differentiation, Brief Report, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Histology, Biology, Non–small cell carcinoma, medicine.disease, Prognosis, Basal (phylogenetics), Cytokeratin, Oncology, TTF-1, ΔNp63/p40, Cancer research, medicine, Copy-number variation, Lung cancer, Lung, RC254-282, Insulin-like growth factor 1 receptor
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cf900f8501228167c9ffcf85d1c5ba1
http://hdl.handle.net/11383/2123676 -
3
المؤلفون: Makoto Sohda, Tomonori Yoshida, Takehiko Yokobori, Hiroyuki Kuwano, Yuji Kumakura, Makoto Sakai, Masahiko Nishiyama, Tatsuya Miyazaki, Bolag Altan, Halin Bao, Susumu Rokudai, Misaki Iijima
المصدر: Cancer Science
مصطلحات موضوعية: 0301 basic medicine, Oncology, squamous cell carcinoma, Male, Cancer Research, Esophageal Neoplasms, Carcinogenesis, medicine.medical_treatment, medicine.disease_cause, Esophageal squamous cell carcinoma, 0302 clinical medicine, esophageal cancer, Aged, 80 and over, General Medicine, Esophageal cancer, Middle Aged, University hospital, Prognosis, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Immunohistochemistry, Original Article, Female, Esophageal Squamous Cell Carcinoma, TP63, medicine.medical_specialty, Disease-Free Survival, 03 medical and health sciences, Internal medicine, Cell Line, Tumor, ΔNp63/p40, medicine, Biomarkers, Tumor, Humans, neoplasms, Aged, Neoplasm Staging, Chemotherapy, business.industry, Tumor Suppressor Proteins, Diagnostic marker, Original Articles, medicine.disease, digestive system diseases, 030104 developmental biology, business, Transcription Factors
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5
المؤلفون: Natasha Rekhtman, Maria E. Arcila, Mark G. Kris, Agnes Colanta, Laura J. Tafe, Lu Wang, Maureen F. Zakowski, Jamie E. Chaft, Andre L. Moreira, Camelia S. Sima, Marc Ladanyi, William D. Travis
المصدر: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
مصطلحات موضوعية: Adult, Male, Neuroblastoma RAS viral oncogene homolog, Pathology, medicine.medical_specialty, Lung Neoplasms, Genotype, EGFR, Kaplan-Meier Estimate, Adenocarcinoma, Biology, medicine.disease_cause, Article, Pathology and Forensic Medicine, 03 medical and health sciences, 0302 clinical medicine, Immunophenotyping, ΔNp63/p40, KRAS, Biomarkers, Tumor, medicine, Carcinoma, Humans, large cell carcinoma, In Situ Hybridization, Fluorescence, Aged, 030304 developmental biology, Aged, 80 and over, 0303 health sciences, Mutation, Large cell, Middle Aged, medicine.disease, Immunohistochemistry, 3. Good health, ALK, TTF-1, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Carcinoma, Large Cell, Female
-
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.